Image guided radiotherapy for prostate cancer

Bulletin du Cancer

Volumn 95, Issue 3, 2008, Pages 374-380

  Soete, Guy ^a   Verellen, Dirk ^a   Storme, Guy ^a  

^a UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

Image guided radiotherapy; Prostate cancer

Indexed keywords

BRACHYTHERAPY; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; DISEASE CONTROL; EXTERNAL BEAM RADIOTHERAPY; HUMAN; PATIENT POSITIONING; PROSTATE CANCER; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; REVIEW; X RAY;

HUMANS; MALE; PROSTATE; PROSTATIC NEOPLASMS; PROSTHESES AND IMPLANTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL;

EID: 42149084495     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2008.0599     Document Type: Review

References (72)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. Cancer statistics 2006. CA Cancer J Clin 2006; 56: 106-30.
2. Zietman AL, Coen JJ, Dallow KC, Shipley WU. The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome. Int J Radiat Oncol Biol Phys 1995; 32: 287-92.
3. Kuban AD, El-Mahdi AM, Schellhammer PF. Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 1995; 32: 307-16.
4. Shipley WU, Verhey LJ, Munzenrider JE, Suit HD, Urie MM, McManus PL, et al. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone. Int J Radiat Oncol Biol Phys 1995; 32: 3-12.
5. Dearnaley DP, Hall E, Lawrence D, Huddart RA, Eeles R, Nutting CM, et al. Phase III pilot study of dose escalation using conformal radiotherapy in prostate cancer: PSA control and side effects. Br J Cancer 2005; 92: 488-98.
6. Pollack A, Zagars GK, Starkschall G, Antolak JA, Lee JJ, Huang E, et al. Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 2002; 53: 1097-105.
7. Zietman AL, DeSilvio ML, Slater JD, Rossi CJ, Miller DW, Adams JA, et al. Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate. A randomized controlled trial. JAMA 2005; 294: 1233-9.
8. Peeters ST, Heemsbergen WD, Koper PC, van Putten WL, Slot A, Dielwart MF, et al. Dose-response in radiotherapy for localized prostate cancer: results of the Dutch multicenter randomized phase III trial comparing 68 Gy of radiotherapy with 78 Gy. J Clin Oncol 2006; 24: 1990-6.
9. International Commission on Radiation units and Measurements. Prescribing, recording and reporting photon beam therapy. ICRU Report 50. Bethesda; 1993.
10. Bel A, van Herk M, Lebesque J. Target margins for random geometrical uncertainties in conformal radiotherapy. Med Phys 1996; 23: 1537-45.
11. van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys 2000; 47: 1121-35.
12. Sherouse GW, Chaney EL. The portable virtual simulator. Int J Radiat Oncol Biol Phys 1991; 21: 475-82.
13. Song PY, Washington M, Vaida F, Hamilton R, Spelbring D, Wyman B, et al. A comparison of four patient immobilization devices in the treatment of prostate cancer patients with three dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 1996; 34: 213-9.
14. Malone S, Szanto J, Perry G, Gerig L, Manion S, Dahrouge S, et al. A prospective comparison of three systems of patient immobilization for prostate radiotherapy. Int J Radiat Oncol Biol Phys 2000; 48: 657-65.
15. Greer PB, Mortensen TM, Jose CC. Comparison of two methods for anterior-posterior isocenter localization in pelvic radiotherapy using electronic portal imaging. Int J Radiat Oncol Biol Phys 1998; 41: 1193-9.
16. MacKay RI, Graham PA, Logue JP, Moore CJ. Patient positioning using detailed three-dimensional surface data for patients undergoing conformal radiation therapy for carcinoma of the prostate: a feasibility study. Int J Radiat Oncol Biol Phys 2001; 49: 225-30.
17. Soete G, Van de Steene J, Verellen D, Vinh-Hung V, Van den Berge D, Michielsen D, et al. Initial clinical experience with infrared-reflecting skin markers in the positioning of patients treated by conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002; 52: 694-8.
18. D'Amico AV, Manola J, Loffredo M, Lopes L, Nissen K, O'Farrell DA, et al. A practical method to achieve prostate gland immobilization and target verification for daily treatment. Int J Radiat Oncol Biol Phys 2001; 51: 1431-6.
19. Wachter S, Gerstner N, Dorner D, Goldner G, Colotto A, Wambersie A, et al. The influence of a rectal balloon tube as internal immobilization device on variations of volumes and dose-volume histograms during treatment course of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002; 52: 91-100.
20. Miralbell R, Mollà M, Arnalte R, Canales S, Vargas E, Linero D, et al. Target repositioning optimization in prostate cancer: is intensity-modulated radiotherapy under stereotactic conditions feasible? Int J Radiat Oncol Biol Phys 2004; 59: 366-71.
21. van Lin EN, van der Vight LP, Witjes JA, Huisman HJ, Leer JW, Visser AG. The effect of an endorectal balloon and off-line correction on the interfraction systematic and random prostate position variations: a comparative study. Int J Radiat Oncol Biol Phys 2005; 61: 278-88.
22. Willoughby TR, Kupelian PA, Pouliot J, Shinohara K, Aubin M, Roach 3rd M, et al. Target localization and real-time tracking using the Calypso 4D localization system in patients with localized prostate cancer. Int J Radiat Oncol Biol Phys 2006; 65: 528-34.
23. Shimizu S, Shirato H, Kitamura K, Shinohara N, Harabayashi T, Tsukamoto T, et al. Use of an implanted marker and real-time tracking of the marker for the positioning of prostate and bladder cancers. Int J Radiat Oncol Biol Phys 2000; 48: 1591-7.
24. Litzenberg D, Dawson LA, Sandler H, Sanda MG, McShan DL, Ten Haken RK, et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys 2002; 52: 699-703.
25. Kitamura K, Shirato H, Shimizu S, Shinohara N, Harabayashi T, Shimizu T, et al. Registration accuracy and possible migration of internal fiducial gold marker implanted in prostate and liver treated with real-time tumor-tracking radiation therapy (RTRT). Int J Radiat Oncol Biol Phys 1999; 43: 719-25.
26. Kupelian PA, Willoughby TR, Meeks SL, Forbes A, Wagner T, Maach M, et al. Intraprostatic fiducials for localization of the prostate gland: monitoring intermarker distances during radiation therapy to test for marker stability. Int J Radiat Oncol Biol Phys 2005; 62: 1291-6.
27. Bergström P, Löfroth P, Widmark A. High-precision conformal radiotherapy (HPCRT) of prostate cancer - A new technique for exact positioning of the prostate at the time of treatment. Int J Radiat Oncol Biol Phys 1998; 42: 305-11.
28. Bollet MA, McNair HA, Hansen VN, Norman A, O'Doherty U, Taylor H, et al. Can digitally reconstructed radiographs (DRRS) replace simulation films in prostate cancer conformal radiotherapy? Int J Radiat Oncol Biol Phys 2003; 57: 1122-30.
29. Hurkmans CW, Remeijer P, Lebesque JV, Mijnheer JB. Set-up verification using portal imaging; review of current clinical practice. Radiother Oncol 2001; 58: 105-20.
30. De Neve W, Van den Heuvel F, Coghe M, Verellen D, De Beukeleer M, Roelstraete A, et al. Interactive use of on-line portal imaging in pelvic radiation. Int J Radiat Oncol Biol Phys 1993; 25: 517-24.
31. Van den Heuvel F, De Neve W, Verellen D, Coghe M, Coen V, Storme G. Clinical implementation of an objective computer-aided protocol for intervention in intra-treatment correction using electronic portal imaging. Radiother Oncol 1995; 35: 232-9.
32. Bel A, Vos PH, Rodrigus PT, Creutzberg CL, Visser AG, Stroom JC, et al. High-pecision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. Int J Radiat Oncol Biol Phys 1996; 35: 321-32.
33. Herman MG, Balter JM, Jaffray DA, McGee KP, Munro P, Shalev S, et al. Clinical use of electronic portal imaging: report of AAPM Radiation Therapy Committee Task Group 58. Med Phys 2001; 28: 712-37.
34. Kirby MC, Williams PC. The use of an electronic portal imaging device for exit dosimetry and quality control measurements. Int J Radiat Oncol Biol Phys 1995; 31: 593-603.
35. Soete G, Verellen D, Michielsen D, Vinh-Hung V, Van de Steene J, Van den Berge D, et al. Clinical use of stereoscopic X-ray positioning of patients treated with conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 2002; 54: 948-52.
36. Verellen D, Soete G, Linthout N, Van Acker S, De Roover P, Vinh-Hung V, et al. Quality assurance of a system for improved target localization and patient set-up that combines real-time infrared tracking and stereoscopic X-ray imaging. Radiother Oncol 2003; 67: 129-41.
37. Soete G, De Cock M, Verellen D, Michielsen D, Keuppens F, Storme G. X-ray assisted positioning of patients treated by conformal are radiotherapy for prostate cancer: comparison of setup accuracy using implanted markers versus bony structures. Int J Radiat Oncol Biol Phys 2007; 67: 823-7.
38. Tenn SE, Solberg TD, Medin PM. Targeting accuracy of an image guided gating system for stereotactic body radiotherapy. Phys Med Biol 2005; 50: 5443-62.
39. Verellen D, Tournel K, Van de Steene J, Linthout N, Wauters T, Vinh-Hung V, et al. Breathing-synchronized irradiation using stereoscopic kV-imaging to limit influence of interplay between leaf motion and organ motion in 3D-CRT and IMRT: Dosimetric verification and first clinical experience. Int J Radiat Oncol Biol Phys 2006; 66: s108-s119.
40. Ghilezan MJ, Jaffray DA, Siewerdsen JH, Van Herk M, Shetty A, Sharpe MB, et al. Prostate gland motion assessed with cine-magnetic resonance imaging (cine-MRI). Int J Radiat Oncol Biol Phys 2005; 62: 406-17.
41. Gibbs IC. Frameless image-guided intracranial and extracranial radiosurgery using the Cyberknife robotic system. Cancer Radiother 2006; 10: 283-7.
42. Court L, Rosen I, Mohan R, Dong L. Evaluation of mechanical precision and alignment uncertainties for an integrated CT/Linac system. Med Phys 2003; 30: 1198-210.
43. Jaffray DA, Siewerdsen JH, Wong JW, Martinez AA. Flat-panel conebeam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys 2002; 53: 1337-49.
44. Mackie TR, Kapatoes J, Ruchala K, Lu W, Wu C, Olivera G, et al. Image guidance for precise conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003; 56: 89-105.
45. Pouliot J, Morin O, Aubin M, Aubry JF, Chen J, Speight J, et al. Mega-voltage cone-beam CT: Recent developments and clinical applications. Cancer Radiother 2006; 10: 258-68.
46. Langen KM, Pouliot J, Anezinos C, Aubin M, Gottschalk AR, Hsu IC, et al. Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys 2003; 57: 635-44.
47. Van den Heuvel F, Powell T. Independent verification of ultrasound based image-guided radiation treatment, using electronic portal imaging and implanted gold markers. Med Phys 2003; 30: 2878-87.
48. Raaymakers BW, Raaijmakers AJ, Kotte AN, Jette D, Lagendijk JJ. Integrating a MRI scanner with a 6 MV radiotherapy accelerator: dose deposition in a transverse magnetic field. Phys Med Biol 2004; 49: 4109-18.
49. Dempsey JF, Benoit D, Fitzsimmons JR, Haghighat A, Li JG, Low DA, et al. A device for realtime 3D image-guided IMRT. Int J Radiat Oncol Biol Phys 2005; 63: s202.
50. Kraft G. Radiobiological and physical basis for radiotherapy with protons and heavier ions. Strahlenther Onkol 1990; 166: 10-3.
51. Enghardt W, Parodi K, Crespo P, Fiedler F, Pawelke J, Pönisch F. Dose quantification from in-beam positron emission tomography. Radiother Oncol 2004; 73: s96-s98.
52. Villeirs GM, Van Vaerenbergh K, Vakaet L, Bral S, Claus F, De Neve WJ, et al. Interobserver delineation variation using CT versus combined CT + MRI in intensity-modulated radiotherapy for prostate cancer. Strahlenther Onkol 2005; 181: 424-30.
53. Wang L, Hricak H, Kattan MW, Chen HN, Scardino PT, Kuroiwa K. Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms. Radiology 2006; 238: 597-603.
54. Wallner KE, Merrick GS, Benson ML, Butler WM, Maki J, Tollenaar BG. Penile bulb imaging. Int J Radiat Oncol Biol Phys 2002; 53: 928-33.
55. Wernicke AG, Valicenti R, Dieva K, Houser C, Pequignot E. Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2004; 60: 1357-63.
56. Mangar SA, Sydes MR, Tucker HL, Coffey J, Sohaib SA, Gianolini S, et al. Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397). Radiother Oncol 2006; 80: 355-62.
57. Futterer JJ, Heijmink SW, Scheenen TW, Veltman J, Huisman HJ, Vos P, et al. Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging. Radiology 2006; 241: 449-58.
58. Cellini N, Morganti AG, Mattiucci GC, Valentini V, Leone M, Luzi S, et al. Analysis of intraprostatic failures in patients treated with hormonal therapy and radiotherapy: implications for conformal therapy planning. Int J Radiat Oncol Biol Phys 2002; 53: 595-9.
59. De Meerleer G, Villeirs G, Bral S, Paelinck L, De Gersem W, Dekuyper P, et al. The magnetic resonance detected intraprostatic lesion in prostate cancer: planning and delivery of intensity-modulated radiotherapy. Radiother Oncol 2005; 75: 325-33.
60. Cooperberg MR, Lubeck DP, Mehta SS, Carroll PR. Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from Capsure). J Urol 2003; 170: S21-S25.
61. Bangma CH, Roemeling S, Schroder FH. Overdiagnosis and overtreatment of early detected prostate cancer. World J Urol 2007; 25: 3-9.
62. Bill-Axelson A, Holmberg L, Ruutu M, Häggman M, Andersson SO, Bratell S, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005; 352: 1977-84.
63. th International Consultation on new developments in prostate cancer. Paris: Health Publications, 2006.
64. Herrmann TR, Rabenalt R, Stolzenburg JU, Liatsikos EN, Imkamp F, Tezval H, et al. Oncological and functional results of open, robot-assisted and laparoscopic radical prostatectomy: does surgical approach and surgical experience matter? World J Urol 2007; 25: 149-60.
65. Fowler Jr. FJ, Barry MJ, Lu-Yao G, Wasson JH, Bin L. Outcomes of external-beam radiation therapy for prostate cancer: a study of medicare beneficiaries in three surveillance, epidemiology and end results areas. J Clin Oncol 1996; 14: 2258-65.
66. Madalinska JB, Essink-Bot ML, de Koning HJ, Kirkels WJ, van der Maas PJ, Schroder FH. Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. J Clin Oncol 2001; 19: 1619-28.
67. Talcott JA, Rieker P, Clark JA, Propert KJ, Weeks JC, Beard CJ, et al. Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study. J Clin Oncol 1998; 16: 275-83.
68. Potosky AL, Legler J, Albertsen PC, Stanford JL, Gilliland FD, Hamilton AS, et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the prostate cancer outcomes study. J Natl Cancer Inst 2000; 92: 1582-92.
69. van Tol-Geerdink JJ, Stalmeier PF, van Lin EN, Schimmel EC, Huizenga H, van Daal WA, et al. Do patients with localized prostate cancer treatment really want more aggressive treatment? J Clin Oncol 2006; 24: 4581-6.
70. Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, et al. Radical prostatectomy, external beam radiotherapy < 72 Gy, external beam radiotherapy ≥ 72 Gy, permanent seed implantation or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer. Int J Radiat Oncol Biol Phys 2004; 58: 25-33.
71. de Crevoisier R, Tucker SL, Dong L, Mohan R, Cheung R, Cox JD, et al. Increased risk of biochemical and local failure in patients with distended rectum on the planning CT for prostate cancer radiotherapy. Int J Radiat Oncol Biol Phys 2005; 62: 965-73.
72. Song WY, Schaly B, Bauman G, Battista JJ, Van Dyk J. Evaluation of image-guided radiation therapy (IGRT) technologies and their impact on the outcomes of hypofractionated prostate cancer treatments: a radiobiologic analysis. Int J Radiat Oncol Biol Phys 2006; 64: 289-300.